Non‐Randomised Comparative Analysis and Cost‐Minimisation Analysis of Macrophage‐Modulating Cream on Mildly Infected Diabetic Foot Ulcers: A Real‐World Preliminary Report
Chia‐Ding Shih, Asad Sayeeduddin, Sean Mauch, Sofia Sakellaridi, Erianthe Ortega, Emily R Rosario · 2026
Read Non‐Randomised Comparative Analysis and Cost‐Minimisation Analysis of Macrophage‐Modulating Cream on Mildly Infected Diabetic Foot Ulcers: A Real‐World Preliminary Report by Chia‐Ding Shih, Asad Sayeeduddin, Sean Mauch, Sofia Sakellaridi, Erianthe Ortega, Emily R Rosario (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13158001.txt.
Description
Six authors, led by Chia-Ding Shih, report early real-world results for a cream that treats diabetic foot ulcers in this 2026 paper. Such ulcers are a serious result of diabetes, and poor healing is driven in part by overactive inflammatory cells called macrophages. The cream, ON101, aims to shift those cells from an attack mode to a repair mode.
The team enrolled patients whose ulcers were Wagner Grade 2 with mild infection. Patients got the cream with weekly follow-up. People on dialysis or with poor blood flow to the foot were excluded. The main measure was healing at four weeks. Twelve cases were analyzed in the end. A second part compared direct costs with a matched group that got standard care. The design tests both whether the cream helps and whether it can save money.
Catalog record
| CREATOR | Chia‐Ding Shih, Asad Sayeeduddin, Sean Mauch, Sofia Sakellaridi, Erianthe Ortega, Emily R Rosario |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |